Pioneer the commercialization of groundbreaking in vivo CRISPR therapy, engaging healthcare providers across Illinois, Indiana, and Wisconsin. Drive strategic relationships while educating on innovative treatment solutions in a complex rare disease market.

Inspire progress at the forefront of gene therapy by leading the launch of the first in vivo CRISPR treatment for hereditary angioedema. This role involves strategic account management, scientific communication, and innovative solutions in a specialized market.

Unlock potential by managing and optimizing Veeva platforms to enhance Medical Affairs and Commercial operations. Collaborate with stakeholders and vendors to drive innovation and efficiency aligned with business objectives.

Join a team that's transforming patient care by pioneering the launch of a groundbreaking in vivo CRISPR therapy. Drive territory management, stakeholder engagement, and scientific education to revolutionize HAE treatment in California and Hawaii.

Pioneer groundbreaking in vivo CRISPR therapies by building trusted relationships with healthcare providers. Lead the successful launch and navigate complex market dynamics to deliver transformative solutions in hereditary angioedema.